Literature DB >> 2264979

Myoclonus, seizures, and paratonia in Alzheimer disease.

S C Risse1, T H Lampe, T D Bird, D Nochlin, S M Sumi, T Keenan, L Cubberley, E Peskind, M A Raskind.   

Abstract

Twenty-eight patients with the clinical diagnosis of probable Alzheimer disease (AD) were followed longitudinally until death. The presence of myoclonus, seizures, and paratonia was monitored as part of this process. At autopsy, 22 of the patients met pathologic criteria for AD and 6 had other degenerative neurologic diseases. Myoclonus was present in 55% of the AD patients and none of the non-AD patients. Seizures were present in 64% of the AD patients, and only 17% of the non-AD patients. Paratonia was found frequently in all patient groups. In most patients, symptoms developed late in the course of their illness. The incidence of myoclonus, seizures, and paratonia in our patients was higher than in most previous studies. The reasons for this finding are discussed.

Entities:  

Mesh:

Year:  1990        PMID: 2264979     DOI: 10.1097/00002093-199040400-00003

Source DB:  PubMed          Journal:  Alzheimer Dis Assoc Disord        ISSN: 0893-0341            Impact factor:   2.703


  24 in total

Review 1.  Why should primary care physicians know about the genetics of dementia?

Authors:  L E Pinsky; W Burke; T D Bird
Journal:  West J Med       Date:  2001-12

Review 2.  Seizures and epilepsy in Alzheimer's disease.

Authors:  Daniel Friedman; Lawrence S Honig; Nikolaos Scarmeas
Journal:  CNS Neurosci Ther       Date:  2011-06-07       Impact factor: 5.243

3.  Alzheimer's disease phenotypes and genotypes associated with mutations in presenilin 2.

Authors:  Suman Jayadev; James B Leverenz; Ellen Steinbart; Justin Stahl; William Klunk; Cheng-En Yu; Thomas D Bird
Journal:  Brain       Date:  2010-04       Impact factor: 13.501

4.  Seizures in Alzheimer disease: who, when, and how common?

Authors:  Nikolaos Scarmeas; Lawrence S Honig; Hyunmi Choi; Julio Cantero; Jason Brandt; Deborah Blacker; Marilyn Albert; Joan C Amatniek; Karen Marder; Karen Bell; W Allen Hauser; Yaakov Stern
Journal:  Arch Neurol       Date:  2009-08

Review 5.  Epidemiology of the dementias: recent developments and new approaches.

Authors:  C M van Duijn
Journal:  J Neurol Neurosurg Psychiatry       Date:  1996-05       Impact factor: 10.154

6.  Neuronal Network Excitability in Alzheimer's Disease: The Puzzle of Similar versus Divergent Roles of Amyloid β and Tau.

Authors:  Syed Faraz Kazim; Joon Ho Seo; Riccardo Bianchi; Chloe S Larson; Abhijeet Sharma; Robert K S Wong; Kirill Y Gorbachev; Ana C Pereira
Journal:  eNeuro       Date:  2021-04-23

Review 7.  Network abnormalities and interneuron dysfunction in Alzheimer disease.

Authors:  Jorge J Palop; Lennart Mucke
Journal:  Nat Rev Neurosci       Date:  2016-11-10       Impact factor: 34.870

8.  Altered longevity-assurance activity of p53:p44 in the mouse causes memory loss, neurodegeneration and premature death.

Authors:  Mariana Pehar; Kenneth J O'Riordan; Melissa Burns-Cusato; Matthew E Andrzejewski; Carlos Gil del Alcazar; Corinna Burger; Heidi Scrable; Luigi Puglielli
Journal:  Aging Cell       Date:  2010-04       Impact factor: 9.304

9.  Seizure susceptibility and mortality in mice that over-express amyloid precursor protein.

Authors:  Cara J Westmark; Pamela R Westmark; Ashley M Beard; Sharon M Hildebrandt; James S Malter
Journal:  Int J Clin Exp Pathol       Date:  2008-01-01

Review 10.  Seizures in elderly patients with dementia: epidemiology and management.

Authors:  Mario Mendez; Gerald Lim
Journal:  Drugs Aging       Date:  2003       Impact factor: 3.923

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.